Skip to main content
Genmab logo

Genmab — Investor Relations & Filings

Ticker · GMAB ISIN · DK0010272202 LEI · 529900MTJPDPE4MHJ122 CO Manufacturing
Open in API
Filings indexed 2,816 across all filing types
Latest filing 2024-04-03 M&A Activity
Country DK Denmark
Listing CO GMAB

About Genmab

https://www.genmab.com/

Genmab is an international biotechnology company that specializes in the creation, development, and commercialization of differentiated antibody therapeutics. The company focuses on transforming the treatment of cancer and other serious diseases. By utilizing proprietary antibody technology platforms and scientific expertise, Genmab develops a pipeline of innovative medicines. Its activities span from discovery and research through clinical development to deliver novel therapies to patients.

Recent filings

Filing Released Lang Actions
Genmab to Broaden and Strengthen Oncology Portfolio with Acquisition of ProfoundBio
M&A Activity Classification · 1% confidence The document is a formal company announcement regarding Genmab's acquisition of ProfoundBio for USD 1.8 billion. It details the transaction terms, strategic rationale, impact on financial guidance, and conference call information. This fits the definition of M&A activity (TAR) as it is a definitive agreement for a corporate takeover.
2024-04-03 English
6-K
Foreign Filer Report
2024-04-02 English
Transaction in Own Shares 2024
Transaction in Own Shares Classification · 1% confidence The document is titled "Transactions in Connection with Share Buy-back Program" and provides detailed tables showing the number of shares repurchased daily under an announced share buy-back program. This activity directly relates to the company managing its own outstanding shares. This aligns perfectly with the definition for 'Transaction in Own Shares' (Code: POS), which covers share repurchase programs.
2024-04-02 English
Transactions in Connection with Share Buy-back Program
Regulatory Filings
2024-04-02 Danish
Transactions in Connection with Share Buy-back Program
Transaction in Own Shares Classification · 1% confidence The document is a company announcement detailing specific transactions executed under a share buy-back program. It provides a table of daily share repurchases, total values, and the updated treasury share position. This falls directly under the definition of 'Transaction in Own Shares' (POS), as it reports the company buying back its own shares.
2024-04-02 English
6-K
Foreign Filer Report
2024-03-25 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.